Genmab AS Correlations

GMAB Stock

USD 19.85 0.27 1.38%

The current 90-days correlation between Genmab AS and Ascendis Pharma AS is 0.02 (i.e., Significant diversification). The correlation of Genmab AS is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Genmab AS Correlation With Market

Significant diversification

The correlation between Genmab AS and DJI is 0.01 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Genmab AS and DJI in the same portfolio, assuming nothing else is changed.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genmab AS. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For information on how to trade Genmab Stock refer to our How to Trade Genmab Stock guide.

Moving together with Genmab Stock

0.65	LLY	Eli Lilly Earnings Call This Week	Pair Corr
0.61	PFE	Pfizer Inc Earnings Call This Week	Pair Corr
0.62	INZY	Inozyme Pharma	Pair Corr
0.67	LPTX	Leap Therapeutics	Pair Corr
0.72	MREO	Mereo BioPharma Group	Pair Corr
0.8	NKTX	Nkarta Inc	Pair Corr
0.74	PDSB	PDS Biotechnology Corp	Pair Corr
0.66	ABBV	AbbVie Inc Earnings Call Tomorrow	Pair Corr
0.68	ABOS	Acumen Pharmaceuticals	Pair Corr
0.75	ADAP	Adaptimmune Therapeutics	Pair Corr
0.68	AMGN	Amgen Inc Earnings Call This Week	Pair Corr
0.62	APTO	Aptose Biosciences	Pair Corr
0.62	DAWN	Day One Biopharmaceu	Pair Corr
0.83	ACET	Adicet Bio	Pair Corr

Moving against Genmab Stock

0.53	BMY	Bristol Myers Squibb Earnings Call This Week	Pair Corr
0.59	FNMFO	Federal National Mortgage	Pair Corr
0.51	MNPR	Monopar Therapeutics	Pair Corr
0.44	TGNA	Tegna Inc	Pair Corr
0.43	AVAL	Grupo Aval	Pair Corr
0.41	CIB	Bancolombia SA ADR Trending	Pair Corr
0.41	DNOW	Now Inc	Pair Corr

Related Correlations Analysis

	ASND	APLS	BGNE	AKRO	BPMC	DAWN	MRTX	AMLX	TERN	LEGN
ASND		0.76	0.58	-0.28	-0.22	-0.5	0.0	-0.41	-0.12	-0.5	ASND
APLS	0.76		0.67	-0.07	-0.02	-0.33	0.0	-0.19	0.03	-0.26	APLS
BGNE	0.58	0.67		0.04	-0.33	-0.03	0.0	0.12	0.23	0.05	BGNE
AKRO	-0.28	-0.07	0.04		0.31	0.35	0.0	0.2	0.03	0.28	AKRO
BPMC	-0.22	-0.02	-0.33	0.31		-0.19	0.0	-0.28	-0.55	-0.25	BPMC
DAWN	-0.5	-0.33	-0.03	0.35	-0.19		0.0	0.91	0.76	0.78	DAWN
MRTX	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	MRTX
AMLX	-0.41	-0.19	0.12	0.2	-0.28	0.91	0.0		0.79	0.79	AMLX
TERN	-0.12	0.03	0.23	0.03	-0.55	0.76	0.0	0.79		0.67	TERN
LEGN	-0.5	-0.26	0.05	0.28	-0.25	0.78	0.0	0.79	0.67		LEGN
	ASND	APLS	BGNE	AKRO	BPMC	DAWN	MRTX	AMLX	TERN	LEGN

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

AMLX	+ 0.91	DAWN
TERN	+ 0.79	AMLX
LEGN	+ 0.79	AMLX
LEGN	+ 0.78	DAWN
APLS	+ 0.76	ASND
TERN	+ 0.76	DAWN

High negative correlations

TERN	- 0.55	BPMC
LEGN	- 0.5	ASND
DAWN	- 0.5	ASND
AMLX	- 0.41	ASND
BPMC	- 0.33	BGNE
DAWN	- 0.33	APLS

Risk-Adjusted Indicators

There is a big difference between Genmab Stock performing well and Genmab AS Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Genmab AS's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
ASND	1.77	0.05	0.00	0.25	1.95	(1.98)	3.56	(3.28)	9.84
APLS	2.51	0.14	0.03	0.26	3.81	(2.56)	4.63	(4.71)	27.73
BGNE	1.82	(0.22)	0.00	(0.45)	0.00	0.00	3.46	(4.30)	17.00
AKRO	4.56	1.34	0.41	0.97	2.61	(6.03)	6.80	(5.05)	97.98
BPMC	2.10	0.43	0.17	0.53	2.05	(2.40)	5.87	(3.53)	19.12
DAWN	1.94	(0.20)	0.00	(0.14)	0.00	0.00	4.00	(3.46)	11.05
MRTX	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
AMLX	3.79	(0.52)	0.00	(0.41)	0.00	0.00	7.40	(8.97)	20.49
TERN	3.11	(0.76)	0.00	(0.83)	0.00	0.00	5.17	(6.75)	26.61
LEGN	2.27	(0.36)	0.00	(0.36)	0.00	0.00	5.06	(5.44)	13.49

Genmab AS Corporate Executives

Elected by the shareholders, the Genmab AS's board of directors comprises two types of representatives: Genmab AS inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Genmab. The board's role is to monitor Genmab AS's management team and ensure that shareholders' interests are well served. Genmab AS's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Genmab AS's outside directors are responsible for providing unbiased perspectives on the board's policies.

Anthony CPA	Executive CFO	Profile
Anthony Mancini	Executive COO	Profile
Rayne Waller	Executive CTO	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC